Age of Discovery (PharmaTimes, November 2017)

| by admin
Article Featured image

Five years on from Pfizer selling Discovery Park, the site’s current chief executive Toby Hunter tells PharmaTimes about the plans for its future.

With around 150 companies working in 14 buildings over 440 acres, and several blockbuster drugs to its name, few sites can match Discovery Park’s significance for the UK life science industry

Read the full article in PharmaTimes.



Want to discuss an investment opportunity with us?

Submit an Opportunity